The effect of local immunity on gastric cancer prognosis

Aim. To study the state of local immunity in patients with gastric adenocarcinoma. Materials and methods. From 2017 to 2018, 45 previously untreated patients with gastric adenocarcinoma (25 with stage IIII, 20 with stage IV) received surgical/combined treatment or chemotherapy, respectively, at t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gulnoz G. Khakimova, Alexey A. Tryakin, Tatyana N. Zabotina, Anna A. Borunova, Olga A. Malikhova, Farruh M. Juraev, Ivan N. Peregorodiev, Elena N. Zaharova, Dmitriy V. Tabakov
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2020
Materias:
Acceso en línea:https://doaj.org/article/7ffbdcd2936c4c7a845bd8bd1400fcf8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7ffbdcd2936c4c7a845bd8bd1400fcf8
record_format dspace
spelling oai:doaj.org-article:7ffbdcd2936c4c7a845bd8bd1400fcf82021-11-30T17:03:34ZThe effect of local immunity on gastric cancer prognosis1815-14341815-144210.26442/18151434.2020.1.200049https://doaj.org/article/7ffbdcd2936c4c7a845bd8bd1400fcf82020-05-01T00:00:00Zhttps://modernonco.orscience.ru/1815-1434/article/viewFile/34174/22586https://doaj.org/toc/1815-1434https://doaj.org/toc/1815-1442Aim. To study the state of local immunity in patients with gastric adenocarcinoma. Materials and methods. From 2017 to 2018, 45 previously untreated patients with gastric adenocarcinoma (25 with stage IIII, 20 with stage IV) received surgical/combined treatment or chemotherapy, respectively, at the Blokhin Scientific Research Center of Oncology. Tumor tissue was taken before treatment. By using flow cytometry there were evaluated the percentage of tumor tissue infiltration by lymphocytes (CD45+CD14-TIL); T cells (CD3+CD19-TIL); B cells (CD3-CD19+TIL); NK cell (CD3-CD16+CD56+TIL); effector cells CD16 (CD16+Perforin+TIL) and CD8 (CD8+Perforin+TIL) with their cytotoxic potential active CD16TIL and active CD8TIL; subpopulations of regulatory T cells NKT cells (CD3+CD16+CD56+TIL), regulatory cells CD4 (CD4+CD25+CD127-TIL) and CD8 (CD8+CD11b-CD28-TIL). The prognostic value of immune cells for overall survival (OS) and progression-free survival (PFS) was assessed. Results. A favorable prognosis factor for progression-free survival in patients with local and locally advanced forms of gastric cancer was an increase in the number of CD3-CD19+TIL (HR 0.862, 95% CI 0.7820.957, p=0.005), and an unfavorable prognosis was an increase in NK cells (CD3-CD16+CD56+TIL); HR 1.382, 95% CI 1.0871.758, p=0.008. The negative effect of the relative content of NK cells (CD3-CD16+CD56+TIL) and NKT cells (CD3+CD16+CD56+TIL) on OS of patients with metastatic gastric cancer noted (HR 1.249, 95% CI 0.9971.564, p=0.053; HR 1.127, 95% CI 1.0251.239, p=0.013). At the same time, an increase in the percentage of tumor tissue infiltration by lymphocytes (CD45+CD14-TIL) and an increase in the age of patients (HR 1.005, 95% CI 1.0021.008, p=0.003; HR 1.098, 95% CI 1.0311.170, p=0.004) reduce the incidence of PFS in patients with metastatic gastric carcinoma. Conclusion. Indices of local immunity can serve as additional prognostic factors for gastric carcinoma.Gulnoz G. KhakimovaAlexey A. TryakinTatyana N. ZabotinaAnna A. BorunovaOlga A. MalikhovaFarruh M. JuraevIvan N. PeregorodievElena N. ZaharovaDmitriy V. TabakovIP Habib O.N.articlegastric adenocarcinomalocal immunitysubpopulations of lymphocytesNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282RUСовременная онкология, Vol 22, Iss 1, Pp 60-65 (2020)
institution DOAJ
collection DOAJ
language RU
topic gastric adenocarcinoma
local immunity
subpopulations of lymphocytes
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle gastric adenocarcinoma
local immunity
subpopulations of lymphocytes
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Gulnoz G. Khakimova
Alexey A. Tryakin
Tatyana N. Zabotina
Anna A. Borunova
Olga A. Malikhova
Farruh M. Juraev
Ivan N. Peregorodiev
Elena N. Zaharova
Dmitriy V. Tabakov
The effect of local immunity on gastric cancer prognosis
description Aim. To study the state of local immunity in patients with gastric adenocarcinoma. Materials and methods. From 2017 to 2018, 45 previously untreated patients with gastric adenocarcinoma (25 with stage IIII, 20 with stage IV) received surgical/combined treatment or chemotherapy, respectively, at the Blokhin Scientific Research Center of Oncology. Tumor tissue was taken before treatment. By using flow cytometry there were evaluated the percentage of tumor tissue infiltration by lymphocytes (CD45+CD14-TIL); T cells (CD3+CD19-TIL); B cells (CD3-CD19+TIL); NK cell (CD3-CD16+CD56+TIL); effector cells CD16 (CD16+Perforin+TIL) and CD8 (CD8+Perforin+TIL) with their cytotoxic potential active CD16TIL and active CD8TIL; subpopulations of regulatory T cells NKT cells (CD3+CD16+CD56+TIL), regulatory cells CD4 (CD4+CD25+CD127-TIL) and CD8 (CD8+CD11b-CD28-TIL). The prognostic value of immune cells for overall survival (OS) and progression-free survival (PFS) was assessed. Results. A favorable prognosis factor for progression-free survival in patients with local and locally advanced forms of gastric cancer was an increase in the number of CD3-CD19+TIL (HR 0.862, 95% CI 0.7820.957, p=0.005), and an unfavorable prognosis was an increase in NK cells (CD3-CD16+CD56+TIL); HR 1.382, 95% CI 1.0871.758, p=0.008. The negative effect of the relative content of NK cells (CD3-CD16+CD56+TIL) and NKT cells (CD3+CD16+CD56+TIL) on OS of patients with metastatic gastric cancer noted (HR 1.249, 95% CI 0.9971.564, p=0.053; HR 1.127, 95% CI 1.0251.239, p=0.013). At the same time, an increase in the percentage of tumor tissue infiltration by lymphocytes (CD45+CD14-TIL) and an increase in the age of patients (HR 1.005, 95% CI 1.0021.008, p=0.003; HR 1.098, 95% CI 1.0311.170, p=0.004) reduce the incidence of PFS in patients with metastatic gastric carcinoma. Conclusion. Indices of local immunity can serve as additional prognostic factors for gastric carcinoma.
format article
author Gulnoz G. Khakimova
Alexey A. Tryakin
Tatyana N. Zabotina
Anna A. Borunova
Olga A. Malikhova
Farruh M. Juraev
Ivan N. Peregorodiev
Elena N. Zaharova
Dmitriy V. Tabakov
author_facet Gulnoz G. Khakimova
Alexey A. Tryakin
Tatyana N. Zabotina
Anna A. Borunova
Olga A. Malikhova
Farruh M. Juraev
Ivan N. Peregorodiev
Elena N. Zaharova
Dmitriy V. Tabakov
author_sort Gulnoz G. Khakimova
title The effect of local immunity on gastric cancer prognosis
title_short The effect of local immunity on gastric cancer prognosis
title_full The effect of local immunity on gastric cancer prognosis
title_fullStr The effect of local immunity on gastric cancer prognosis
title_full_unstemmed The effect of local immunity on gastric cancer prognosis
title_sort effect of local immunity on gastric cancer prognosis
publisher IP Habib O.N.
publishDate 2020
url https://doaj.org/article/7ffbdcd2936c4c7a845bd8bd1400fcf8
work_keys_str_mv AT gulnozgkhakimova theeffectoflocalimmunityongastriccancerprognosis
AT alexeyatryakin theeffectoflocalimmunityongastriccancerprognosis
AT tatyananzabotina theeffectoflocalimmunityongastriccancerprognosis
AT annaaborunova theeffectoflocalimmunityongastriccancerprognosis
AT olgaamalikhova theeffectoflocalimmunityongastriccancerprognosis
AT farruhmjuraev theeffectoflocalimmunityongastriccancerprognosis
AT ivannperegorodiev theeffectoflocalimmunityongastriccancerprognosis
AT elenanzaharova theeffectoflocalimmunityongastriccancerprognosis
AT dmitriyvtabakov theeffectoflocalimmunityongastriccancerprognosis
AT gulnozgkhakimova effectoflocalimmunityongastriccancerprognosis
AT alexeyatryakin effectoflocalimmunityongastriccancerprognosis
AT tatyananzabotina effectoflocalimmunityongastriccancerprognosis
AT annaaborunova effectoflocalimmunityongastriccancerprognosis
AT olgaamalikhova effectoflocalimmunityongastriccancerprognosis
AT farruhmjuraev effectoflocalimmunityongastriccancerprognosis
AT ivannperegorodiev effectoflocalimmunityongastriccancerprognosis
AT elenanzaharova effectoflocalimmunityongastriccancerprognosis
AT dmitriyvtabakov effectoflocalimmunityongastriccancerprognosis
_version_ 1718406389413445632